Tetanus Toxoid IgG
Test Mnemonic
TETAN
CPT Codes
- 86317 - QTY (1)
LOINC ®
6367-7
Aliases
- Anti-tetanus toxoid IgG
- C. tetani
- Clostridium tetani
- Tetanus Immune Response
- Tetanus toxoid antibodies
- Tetanus toxoid antibodies
Performing Laboratory
ARUP
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Serum | SST (Gold) | Refrigerated | Separate serum from cells ASAP or within 2 hours of collection. 'Pre' and 'post' vaccine specimens may be submitted separately or together and post specimens must be received within 60 days from receipt of the pre specimens. Label specimens plainly as 'pre-vaccine' and 'post-vaccine.' |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.2 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Ambient | After separation from cells: 48 hours |
| Refrigerated | After separation from cells: 2 weeks |
| Frozen | After separation from cells: 1 year (Avoid repeated freeze/thaw cycles) |
Days Performed
Sun - Sat
Turnaround Time
2 - 4 days
Methodology
| Name | Description |
|---|---|
| Quantitative Multiplex Bead Assay |
Reference Range
| Tetanus IgG Abs | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| > 0.1 IU/mL is usually considered protective |
Special Info
'Pre' and 'post' vaccine specimens can be submitted separately or together for testing; if shipped separately, post specimen must be received within 60 days of pre specimen. Mark specimens plainly as 'pre-vaccine" or 'post-vaccine'. This test is New York DOH approved.
Clinical Info
Responder status is determined according to the ratio of a one-month post-vaccination sample to pre-vaccination concentration of tetanus IgG antibodies as follows: (1) If the post-vaccination concentration is <1.0 IU, the patient is considered to be a nonresponder. (2) If the post-vaccination is greater that or equal to 1.0 IU, a patient with a ratio of less than 1.5 is a nonresponder, a ratio of 1.5 to <3.0, a weak responder, and a ratio of 3.0 or greater, a good responder. (3) If the pre-vaccination concentration is >1.0, it may be difficult to assess the response based on a ratio alone. A post-vaccination >2.5 IU in this case is usually adequate.